Published in Blood Weekly, September 26th, 2002
Net revenues for the second quarter of 2002 totaled $37.3 million as compared with $27.2 million in the second quarter of 2001. Net income for the second quarter of 2002 was $3.8 million or $0.15 per diluted share compared with $4.8 million or $0.20 per diluted share in the prior year.
Net revenues for the first 6 months of 2002 totaled $68.8 million as compared with $53.6 million in the first half of 2001. Net income for the first half of 2002 was $6.5 million, or $0.26 per diluted share compared with $9.2 million, or $0.38 per diluted share for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.